Study record
The unexplored Nexus: Mitochondria derived microproteins and Parkinson's disease
Patel K, Soni R, Shah J · Pathol Res Pract · 2025
What this study reported
Reviewed the literature on mitochondria-derived microproteins, including humanin, small humanin-like peptides and MOTS-c, in relation to Parkinson's disease pathogenesis. Summarised their reported involvement in mitochondrial dysfunction, oxidative stress, neuroinflammation and impaired autophagy across cell and animal models, and identified them as candidate targets for further mechanistic research.
Limitations
Narrative review with no stated search strategy, inclusion criteria or risk-of-bias assessment; MOTS-c is covered only as one of several peptides and the underlying evidence is preclinical.
Study record
| Study model | Review |
|---|---|
| Substance studied | SeveralMore than one of these is central to the paper (common for reviews). |
| Species | Not reported |
| System studied | Narrative review of mitochondria-derived microproteins (humanin, SHLPs, MOTS-c) in Parkinson's disease |
| Population | Not reported |
| Design | Narrative review |
| Sample size as reported | Not reported |
| Control group | Not reported |
| Route (data field only) | Not reported |
| Endpoints measured | mitochondrial dysfunction; oxidative stress; neuroinflammation; autophagy; dopaminergic neuron degeneration |
| Pathways measured | Oxidative stress · Inflammation · Autophagy / mitophagy |
| Research areas | Nervous system · Mitochondrial biology |
| Evidence tier | R — Review (context, not evidence) |
| Publication types | Journal Article, Review |
Appraisal
Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.
- Relevance to MOTS-c
- Indirect
- Model applicability
- n/a
- Sample size
- n/a
- Controls
- n/a
- Outcome validity
- n/a
- Support for its own conclusion
- Weak
Provenance
- Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
- Annotated from the published abstract.
- Editorial review: approved (2026-11-11).
- Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.